BSE filing, NSE: KROSS. Summary written from the filing by ALFA Finder's alert engine.
Kross Ltd: key numbers
- Share price
- ₹296.00
- Market cap
- ₹1,909 Cr
- Revenue (annual)
- ₹673.2 Cr
- Net profit (annual)
- ₹55.21 Cr
- P/E (TTM)
- 27.5×Sector 31.4×
- Promoter holding
- 68.57%+0.00% QoQ
- FII holding
- 3.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kross Ltd
All →Kross Other Announcement
Kross Ltd filed its quarterly shareholding pattern for September 2026 under Regulation 31(1)(b), with promoter holding at 68.57%. The filing also corrects the lock-in disclosure for promoter shares of Sumeet Rai and Kunal Rai.
Kross Earnings Call Transcript: Key Takeaways
Kross reported robust 80% revenue growth driven by commercial vehicle and trailer segments.
- Call
- Guides 45% growth
Kross Investor Presentation: Key Takeaways
Kross Limited reported strong Q2FY27 performance with 79.6% revenue growth, driven by capacity expansion and robust OEM demand in M&HCV and Trailer segments.
Kross Results Update
Kross Limited reported strong Q2 FY27 performance with revenue of ₹235.09 crore and PAT of ₹19.69 crore, driven by robust demand across key automotive segments.
Kross Q2 FY27 Results: Net Profit ₹19.7 Cr, Up 143.2% YoY
Kross Ltd reported revenue from operations of ₹235.1 Cr (+79.6% YoY) and net profit of ₹19.7 Cr (+143.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹19.7 Cr · +143.2% YoY
Kross Board Meeting Date
Kross Limited announced a board meeting scheduled for October 17, 2026, to consider and approve unaudited financial results for the quarter ended September 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.